Dr. Ueno is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
701 Ilalo Street, Room 622
Honolulu, HI 96813Phone+1 808-586-3013- Is this information wrong?
Summary
- I am a board-certified internist and medical oncologist. I specialize in taking care of patients with inflammatory breast cancer, triple negative breast cancer, metastatic breast cancer, and bone metastasis. I have a passion to provide the best care to my patients.
Education & Training
UT Graduate School of Biomedical SciencePhD, Cancer Biology, 1994 - 1999
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1993 - 1996
UPMC Medical EducationResidency, Internal Medicine, 1990 - 1993- OtherClass of 1989
Certifications & Licensure
HI State Medical License 2022 - 2026
TX State Medical License 1993 - 2024
FL State Medical License 2021 - 2023
OK State Medical License 2020 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regents’ Outstanding Teaching Award The University of Texas System, 2013
Clinical Trials
- Herceptin and GM-CSF for Metastatic Breast Cancer Start of enrollment: 2002 Aug 01
- Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer Start of enrollment: 2007 Apr 17
Roles: Contact, Principal Investigator
- Denosumab for Breast Cancer With Bone Mets Start of enrollment: 2015 Feb 09
- Join now to see all
Publications & Presentations
PubMed
- Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer.Faina Nakhlis, Samuel M Niman, Naoto T Ueno, Elizabeth Troll, Sean Ryan, Eren Yeh, Laura Warren, Jennifer Bellon, Beth Harrison, Toshiaki Iwase, H T Carisa Le-Petross,...> ;Breast Cancer Research and Treatment. 2024 Apr 1
- Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative Breast Cancer Subtypes.Reva K Basho, Li Zhao, Jason B White, Lei Huo, Roland L Bassett, Elizabeth A Mittendorf, Alastair Thompson, Jennifer K Litton, Naoto Ueno, Banu Arun, Bora Lim, Vicente...> ;JCO Precision Oncology. 2024 Mar 1
- TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.Filipa Lynce, Laura E Stevens, Zheqi Li, Jane E Brock, Anushree Gulvady, Ying Huang, Faina Nakhlis, Ashka Patel, Jeremy M Force, Tufia C Haddad, Naoto Ueno, Vered Stea...> ;Breast Cancer Research. 2024 Jan 31
- Join now to see all
Journal Articles
- Rates of Immune Cell Infiltration in Patients with Triple-Negative Breast Cancer by Molecular SubtypeWendy A Woodward, Naoto T Ueno, Savitri Krishnamurthy, Bora Lim, PLoS One
- Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast CancerMichael C Stauder, Anthony Lucci, Wendy A Woodward, Bora Lim, Naoto T Ueno, ScienceDirect
Authored Content
- Eicosapentaenoic Acid in Combination with EPHA2 Inhibition Shows Efficacy in Preclinical Models of Triple-Negative Breast Cancer by Disrupting Cellular Cholesterol EffluxNovember 2018
- Eicosapentaenoic Acid in Combination with EPHA2 Inhibition Shows Efficacy in Preclinical Models of Triple-Negative Breast Cancer by Disrupting Cellular Cholesterol EffluxNovember 2018
- Eicosapentaenoic Acid in Combination with EPHA2 Inhibition Shows Efficacy in Preclinical Models of Triple-Negative Breast Cancer by Disrupting Cellular Cholesterol EffluxNovember 2018
- Eicosapentaenoic Acid in Combination with EPHA2 Inhibition Shows Efficacy in Preclinical Models of Triple-Negative Breast Cancer by Disrupting Cellular Cholesterol EffluxNovember 2018
- An Oncologist-Turned-Cancer-Patient’s Plea to ColleaguesMay 2018
- An Oncologist-Turned-Cancer-Patient’s Plea to ColleaguesMay 2018
- My Methodology: How I Treat Inflammatory Breast CancerApril 2018
- 5 Items Patients (And You) Should Complete to Prepare for the End of LifeJanuary 2018
- Prior Systemic Treatment Increased the Incidence of Somatic Mutations in Metastatic Breast CancerJanuary 2018
- Join now to see all
Press Mentions
Five Questions with Dr. Naoto Ueno, UH Cancer Center's New DirectorJanuary 30th, 2023- MD Anderson Research Highlights for December 19, 2022December 19th, 2022
- Oncologist to Lead Northwell Health Cancer InstituteOctober 18th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Japanese
Hospital Affiliations
- Kapiolani Medical Center for Women & ChildrenHonolulu, Hawaii
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
